---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-025648"
form_type: "8-K"
ticker: "MLAB"
cik: "0000724004"
company_name: "MESA LABORATORIES INC /CO/"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T10:21:33.859209+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Mesa Labs Q2 revenue up 64% but GAAP EPS down 65%; non-GAAP AOI up 55%

## Summary
- Revenue $58.7M (+64% YoY); organic growth 12% (18% constant currency). Net income $1.3M (-65%), diluted EPS $0.24.
- GAAP operating income $4.0M (-5%); non-GAAP AOI $15.5M (+55%), $2.88 per diluted share.
- Segments: Clinical Genomics $18.4M (+27% seq), Sterilization $17.0M (+21% org), Biopharma $12.1M (+15% org), Calibration $11.2M flat.
- H1 revenue $109.2M (+54%); GAAP operating loss $0.6M, net loss $0.1M; non-GAAP AOI $21.6M (+13%).

## SEC filing metadata
- accession: 0001437749-22-025648
- form_type: 8-K
- ticker: MLAB
- cik: 0000724004
- company_name: MESA LABORATORIES INC /CO/
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/724004/000143774922025648/0001437749-22-025648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/724004/000143774922025648/mlab20221102_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-025648
- JSON: https://secwatch.observer/filing/0001437749-22-025648.json
- Plain text: https://secwatch.observer/filing/0001437749-22-025648.txt

## Key facts
- Earnings Releases
  MESA LABORATORIES INC /CO/ reported three and six months ended September 30, 2022 results: revenue $58,749, net income $1,306, EPS $0.24 per diluted share.
  - Period: three and six months ended September 30, 2022
  - Revenue: $58,749
  - Net income: $1,306
  - EPS: $0.24 per diluted share
  - Result: reported results
  source text: In comparison to the same quarter in the prior year (“2Q22”), revenues increased 64% to $58,749, operating income decreased 5% to $3,995 and net income was $1,306, a decrease of 65% or $0.24 per diluted share of common stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/724004/000143774922025648/0001437749-22-025648-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.